J9048 Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg

Short descriptor: Inj, bortezomib freseniuskab

✓ Active HCPCS Level II 2026
Open J9048 in the app →

Look up J9048 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

J9048 is the HCPCS Level II code for Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2023-01-01
2026 Maintenance
No change this year

Drug Details

Drug / Substance
bortezomib, not therapeutically equivalent to j9041
Dose / Unit
0.1 mg
Route
Injection

See the full HCPCS Table of Drugs (J-codes).

References

Cite This Page

Reference J9048 with the canonical source and edition:

J9048 — Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J9048

Canonical URL: https://icd10codingpro.com/hcpcs-codes/J9048

Related Codes in Section J

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial